Cargando…
Expression of Syk and MAP4 proteins in ovarian cancer
PURPOSE: We have previously reported on the prognostic importance of the calpain family of proteins in ovarian cancer, especially calpain-2. Spleen tyrosine kinase (Syk) phosphorylates a variety of cytoskeletal proteins with studies suggesting potential interactions between Syk and conventional calp...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6435630/ https://www.ncbi.nlm.nih.gov/pubmed/30737623 http://dx.doi.org/10.1007/s00432-019-02856-9 |
_version_ | 1783406674714820608 |
---|---|
author | Zhang, Siwei Deen, Suha Storr, Sarah J. Yao, Anqi Martin, Stewart G. |
author_facet | Zhang, Siwei Deen, Suha Storr, Sarah J. Yao, Anqi Martin, Stewart G. |
author_sort | Zhang, Siwei |
collection | PubMed |
description | PURPOSE: We have previously reported on the prognostic importance of the calpain family of proteins in ovarian cancer, especially calpain-2. Spleen tyrosine kinase (Syk) phosphorylates a variety of cytoskeletal proteins with studies suggesting potential interactions between Syk and conventional calpains. Microtubule-associated protein 4 (MAP4) has been reported to be regulated by Syk. METHODS: The current study assessed Syk and MAP4 protein expression, by immunohistochemistry on a tissue microarray comprised of cores from primary ovarian carcinomas (n = 575), to evaluate associations with patient clinical outcomes and other clinicopathological factors and sought to determine whether there were any correlations between the expression of Syk, MAP4 and the calpain system. RESULTS: MAP4 expression was significantly associated with ovarian cancer histological subtype (P < 0.001), stage (P = 0.001), grade (P < 0.001) and residual tumour (P = 0.005). Despite this finding, we found no significant association existing between MAP4 expression and overall survival. Syk expression was also found significantly associated with histological subtype (P < 0.001). Syk seems to play a contradictory role with respect to tumour progression: low cytoplasmic Syk expression was significantly associated with low stage (P = 0.013), and low nuclear Syk expression with chemo-resistance in patients treated with taxane-containing therapy (P = 0.006). Interestingly, despite the lack of association in the whole cohort, high nuclear Syk expression was significantly associated with better overall survival in certain subgroups (P = 0.001). CONCLUSIONS: The current study indicates a lack of correlation between calpain-2 expression and Syk and MAP4. Syk, MAP4 and calpain-1 appeared to significantly correlate with each other in the whole cohort, with calpain-1 being more highly associated with MAP4 and Syk in mucinous carcinomas. Overall, the current results suggest that Syk, MAP4, and calpain-1 expression are correlated with each other and these proteins may be involved in early stages of tumour spread. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00432-019-02856-9) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6435630 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-64356302019-04-15 Expression of Syk and MAP4 proteins in ovarian cancer Zhang, Siwei Deen, Suha Storr, Sarah J. Yao, Anqi Martin, Stewart G. J Cancer Res Clin Oncol Original Article – Cancer Research PURPOSE: We have previously reported on the prognostic importance of the calpain family of proteins in ovarian cancer, especially calpain-2. Spleen tyrosine kinase (Syk) phosphorylates a variety of cytoskeletal proteins with studies suggesting potential interactions between Syk and conventional calpains. Microtubule-associated protein 4 (MAP4) has been reported to be regulated by Syk. METHODS: The current study assessed Syk and MAP4 protein expression, by immunohistochemistry on a tissue microarray comprised of cores from primary ovarian carcinomas (n = 575), to evaluate associations with patient clinical outcomes and other clinicopathological factors and sought to determine whether there were any correlations between the expression of Syk, MAP4 and the calpain system. RESULTS: MAP4 expression was significantly associated with ovarian cancer histological subtype (P < 0.001), stage (P = 0.001), grade (P < 0.001) and residual tumour (P = 0.005). Despite this finding, we found no significant association existing between MAP4 expression and overall survival. Syk expression was also found significantly associated with histological subtype (P < 0.001). Syk seems to play a contradictory role with respect to tumour progression: low cytoplasmic Syk expression was significantly associated with low stage (P = 0.013), and low nuclear Syk expression with chemo-resistance in patients treated with taxane-containing therapy (P = 0.006). Interestingly, despite the lack of association in the whole cohort, high nuclear Syk expression was significantly associated with better overall survival in certain subgroups (P = 0.001). CONCLUSIONS: The current study indicates a lack of correlation between calpain-2 expression and Syk and MAP4. Syk, MAP4 and calpain-1 appeared to significantly correlate with each other in the whole cohort, with calpain-1 being more highly associated with MAP4 and Syk in mucinous carcinomas. Overall, the current results suggest that Syk, MAP4, and calpain-1 expression are correlated with each other and these proteins may be involved in early stages of tumour spread. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00432-019-02856-9) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2019-02-08 2019 /pmc/articles/PMC6435630/ /pubmed/30737623 http://dx.doi.org/10.1007/s00432-019-02856-9 Text en © The Author(s) 2019 OpenAccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Article – Cancer Research Zhang, Siwei Deen, Suha Storr, Sarah J. Yao, Anqi Martin, Stewart G. Expression of Syk and MAP4 proteins in ovarian cancer |
title | Expression of Syk and MAP4 proteins in ovarian cancer |
title_full | Expression of Syk and MAP4 proteins in ovarian cancer |
title_fullStr | Expression of Syk and MAP4 proteins in ovarian cancer |
title_full_unstemmed | Expression of Syk and MAP4 proteins in ovarian cancer |
title_short | Expression of Syk and MAP4 proteins in ovarian cancer |
title_sort | expression of syk and map4 proteins in ovarian cancer |
topic | Original Article – Cancer Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6435630/ https://www.ncbi.nlm.nih.gov/pubmed/30737623 http://dx.doi.org/10.1007/s00432-019-02856-9 |
work_keys_str_mv | AT zhangsiwei expressionofsykandmap4proteinsinovariancancer AT deensuha expressionofsykandmap4proteinsinovariancancer AT storrsarahj expressionofsykandmap4proteinsinovariancancer AT yaoanqi expressionofsykandmap4proteinsinovariancancer AT martinstewartg expressionofsykandmap4proteinsinovariancancer |